65293-003 : Kengreal 50 mg Intravenous Injection, Powder, Lyophilized, for Solution
NDC: | 65293-003 |
Labeler: | The Medicines Company |
Product Type: | Human Prescription Drug |
Drug Name: | Kengreal |
Dosage Form: | Intravenous Injection, Powder, Lyophilized, for Solution |
Application #: | NDA204958 |
Rev. Date: |
NDC Package Codes:
- 65293-003-10: 10 VIAL, SINGLE‑USE IN 1 CARTON (65293‑003‑10) > 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION IN 1 VIAL, SINGLE‑USE (65293‑003‑01)
Active Ingredients:
- Cangrelor
Dosage Strength:
- 50 mg
Pharmaceutical Classes:
- P2Y12 Platelet Inhibitor [EPC]
- Decreased Platelet Aggregation [PE]
- P2Y12 Receptor Antagonists [MoA]
Related Products:
Based on records with the same trade name.- 10122-620 Kengreal 50 mg Intravenous Injection, Powder, Lyophilized, for Solution by Chiesi USA, Inc.
NDC QR Code
Scan the QR code below to easily reference this data in the future:< Prev: 65293-001Next: 65293-005 >
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.